TipRanks
Medicenna Therapeutics Corp (MDNAF)
OTHER OTC:MDNAF
US Market
MDNAF
Medicenna Therapeutics Corp
RESEARCH TOOLSreports

Medicenna Therapeutics Corp (MDNAF) Financial Statements

251 Followers

Medicenna Therapeutics Corp Financial Overview

Medicenna Therapeutics Corp's market cap is currently $25.27M. The company's EPS TTM is $-0.2218; its P/E ratio is -2.07; Medicenna Therapeutics Corp is scheduled to report earnings on August 14, 2026, and the estimated EPS forecast is $-0.03. See an overview of income statement, balance sheet, and cash flow financials.
Mar 26Mar 25Mar 24Mar 23Mar 22
Income Statement
Total RevenueC$ 0.00C$ 0.00C$ 0.00C$ 0.00C$ 0.00
Gross ProfitC$ -77.00KC$ -55.00KC$ -5.00KC$ -5.00KC$ -38.00K
Operating IncomeC$ -23.71MC$ -21.63MC$ -19.66MC$ -21.64MC$ -22.30M
EBITDAC$ -23.64MC$ -12.98MC$ -18.67MC$ -16.30MC$ -22.54M
Net IncomeC$ -18.41MC$ -11.80MC$ -25.47MC$ 1.55MC$ -22.65M
Balance Sheet
Cash & Short-Term InvestmentsC$ 6.25MC$ 24.84MC$ 16.98MC$ 33.60MC$ 20.54M
Total AssetsC$ 8.45MC$ 28.38MC$ 19.13MC$ 36.45MC$ 23.46M
Total DebtC$ 119.00KC$ 168.00KC$ 0.00C$ 0.00C$ 0.00
Net DebtC$ -6.13MC$ -24.67MC$ -16.98MC$ -33.60MC$ -20.54M
Total LiabilitiesC$ 5.97MC$ 9.29MC$ 13.94MC$ 6.96MC$ 2.62M
Stockholders' EquityC$ 2.48MC$ 19.09MC$ 5.19MC$ 29.49MC$ 20.84M
Cash Flow
Free Cash FlowC$ 0.00C$ -16.52MC$ -16.26MC$ -12.66MC$ -23.58M
Operating Cash FlowC$ -17.92MC$ -16.49MC$ -16.26MC$ -12.66MC$ -23.58M
Investing Cash FlowC$ 2.00KC$ -33.00KC$ 0.00C$ -13.05MC$ 10.05M
Financing Cash FlowC$ -19.00KC$ 23.49MC$ 0.00C$ 24.76MC$ 3.88M
Currency in CAD

Medicenna Therapeutics Corp Earnings and Revenue History

Income Statement >

Medicenna Therapeutics Corp Debt to Assets

Balance Sheet >

Medicenna Therapeutics Corp Cash Flow

Cash Flow >

Medicenna Therapeutics Corp Forecast EPS vs Actual EPS

Earnings >